Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
15 Leser
Artikel bewerten:
(0)

Frost & Sullivan Will Reveal The Transformational Shift of The Medical Technologies Industry at BioMEDevice Boston Event

Keynote speaker Brahadeesh Chandrasekaran discusses 'The Future is Today: An Outlook on the State of the Medical Technologies Industry'

SANTA CLARA, California, May 1, 2017 /PRNewswire/ --Brahadeesh Chandrasekaran, Transformational Health Industry Analyst at Frost & Sullivan, will present on at BIOMEDevice Boston, May 4th, 2017 at the Boston Convention and Exhibition Center in Boston, MA, in partnership with the Massachusetts Medical Device Industry Council (MassMEDIC).

Chandrasekaran will focus on the change in provider behavior that is leaving to the transformational shift in the industry through factors such as digitization, business and sales model changes, new services around core products and consumerization mind-set. He will discuss on how Medical Technologies is transforming to a customer-focused industry and how companies react to this transformational shift.

"In the past, product based business models worked. But now, moving forward, successful Medtech companies need to develop new models that gives them capability to sell their solutions," explains Chandrasekaran. While the push for value-based healthcare continues, changing business and sales models is not an overnight fix from a Medtech company point of view. These changes require building new capabilities and redefining the business models. "It will be a multi-year journey that will require dedicated resources and time," he adds.

Why you should attend:

  • Discover the key factors shaping the future of Medtech industry.
  • Find out the healthcare spending is shift by 2025.
  • Identify think-tanks in Medtech industry focus in future from Frost & Sullivan's CEO survey 2016.
  • Learn about the new revenue streams thanks to a successful service-oriented business model.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.

Contact:

Mariana Fernandez
Corporate Communications -North America
P: +54 (11) 4778 3540
E:mariana.fernandez@frost.com

https://ww2.frost.com
twitter: @FS_Healthcare
LinkedIn: Transform Health

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.